surmount trial tirzepatide SURMOUNT-5: shows superior weight loss over semaglutide surmount-1 trial tirzepatide weight loss

Ozempic has been linked to an increased risk of gallbladder problems, including gallstones

Absolute contraindications from the Zepbound label apply at any dose: Personal or family history of medullary thyroid carcinoma or MEN-2 syndrome Prior serious hypersensitivity reaction to tirzepatide Active pancreatitis or significantly elevated pancreatitis risk Severe gastroparesis (tirzepatide slows gastric emptying further) Type 1 diabetes Current or planned pregnancy within 1 month History of suicidal ideation per the Zepbound label warning Goal-fit contraindications are the part competitors skip

This finding suggests that GLP-1 receptor agonists may have direct or indirect effects on erectile function beyond what can be explained by metabolic improvements alone

National Institute for Health and Care Excellence

Frequently asked questions Is Zepbound FDA-approved for children under 12

Investigation may include evaluation for bacterial infection, contact dermatitis from alcohol wipes or adhesive materials, or unrelated dermatological conditions